AHG - Company ID 0001702318
The table below shows Akso Health Group's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$12.79M | $1.18M | $1.35M | -$3.25M | -$8.63M | $10.06M |
| Capital expenditure | $1.64K | $154.46K | - | - | - | - |
| Investing cash flow | -$163.46M | -$105.91M | -$54.72M | $18.47M | -$19.96M | -$662.00 |
| Dividends paid | - | - | - | - | - |
Akso Health Group reported operating cash flow of -$12.79M for fiscal year 2026. That is down 1186.6% from $1.18M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow declined from $8.19M (FY 2017) to -$12.79M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $350.00K | $195.88M | $131.65M | -$27.51M | $34.78M | -$9.04M |